CHAD and breast carcinoma: To test whether COL1A1 and CHAD were driving the metastasis phenotype in human breast cancer, we used CRISPRi20 to create a pooled population of COL1A1 and CHAD knockdown in the Her2 amplified, COL1A1/CHAD amplified breast cancer line BT-474.